Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Evaluation of a health service adopting proactive approach to reduce high risk of lung cancer: The Liverpool Healthy Lung Programme.

Ghimire B, Maroni R, Vulkan D, Shah Z, Gaynor E, Timoney M, Jones L, Arvanitis R, Ledson M, Lukehirst L, Rutherford P, Clarke F, Gardner K, Marcus MW, Hill S, Fideo D, Mason S, Smith SG, Quaife SL, Fitzgerald K, Poirier V, Duffy SW, Field JK.

Lung Cancer. 2019 Aug;134:66-71. doi: 10.1016/j.lungcan.2019.05.026. Epub 2019 May 29.

PMID:
31319997
2.

DPP-4 Inhibitor Dose Selection According to Manufacturer Specifications: A Contemporary Experience From UK General Practice.

Spanopoulos D, Busse M, Webb J, Tebboth A, Gollop ND, Marcus MW.

Clin Ther. 2019 Jun 1. pii: S0149-2918(19)30255-3. doi: 10.1016/j.clinthera.2019.05.010. [Epub ahead of print]

PMID:
31164243
3.

Probability of cancer in lung nodules using sequential volumetric screening up to 12 months: the UKLS trial.

Marcus MW, Duffy SW, Devaraj A, Green BA, Oudkerk M, Baldwin D, Field J.

Thorax. 2019 Aug;74(8):761-767. doi: 10.1136/thoraxjnl-2018-212263. Epub 2019 Apr 26.

PMID:
31028232
4.

Genetic interaction analysis among oncogenesis-related genes revealed novel genes and networks in lung cancer development.

Li Y, Xiao X, Bossé Y, Gorlova O, Gorlov I, Han Y, Byun J, Leighl N, Johansen JS, Barnett M, Chen C, Goodman G, Cox A, Taylor F, Woll P, Wichmann HE, Manz J, Muley T, Risch A, Rosenberger A, Han J, Siminovitch K, Arnold SM, Haura EB, Bolca C, Holcatova I, Janout V, Kontic M, Lissowska J, Mukeria A, Ognjanovic S, Orlowski TM, Scelo G, Swiatkowska B, Zaridze D, Bakke P, Skaug V, Zienolddiny S, Duell EJ, Butler LM, Houlston R, Artigas MS, Grankvist K, Johansson M, Shepherd FA, Marcus MW, Brunnström H, Manjer J, Melander O, Muller DC, Overvad K, Trichopoulou A, Tumino R, Liu G, Bojesen SE, Wu X, Le Marchand L, Albanes D, Bickeböller H, Aldrich MC, Bush WS, Tardon A, Rennert G, Teare MD, Field JK, Kiemeney LA, Lazarus P, Haugen A, Lam S, Schabath MB, Andrew AS, Bertazzi PA, Pesatori AC, Christiani DC, Caporaso N, Johansson M, McKay JD, Brennan P, Hung RJ, Amos CI.

Oncotarget. 2019 Mar 5;10(19):1760-1774. doi: 10.18632/oncotarget.26678. eCollection 2019 Mar 5.

5.

Elevated Platelet Count Appears to Be Causally Associated with Increased Risk of Lung Cancer: A Mendelian Randomization Analysis.

Zhu Y, Wei Y, Zhang R, Dong X, Shen S, Zhao Y, Bai J, Albanes D, Caporaso NE, Landi MT, Zhu B, Chanock SJ, Gu F, Lam S, Tsao MS, Shepherd FA, Tardon A, Fernández-Somoano A, Fernandez-Tardon G, Chen C, Barnett MJ, Doherty J, Bojesen SE, Johansson M, Brennan P, McKay JD, Carreras-Torres R, Muley T, Risch A, Wichmann HE, Bickeboeller H, Rosenberger A, Rennert G, Saliba W, Arnold SM, Field JK, Davies MPA, Marcus MW, Wu X, Ye Y, Le Marchand L, Wilkens LR, Melander O, Manjer J, Brunnström H, Hung RJ, Liu G, Brhane Y, Kachuri L, Andrew AS, Duell EJ, Kiemeney LA, van der Heijden EH, Haugen A, Zienolddiny S, Skaug V, Grankvist K, Johansson M, Woll PJ, Cox A, Taylor F, Teare DM, Lazarus P, Schabath MB, Aldrich MC, Houlston RS, McLaughlin J, Stevens VL, Shen H, Hu Z, Dai J, Amos CI, Han Y, Zhu D, Goodman GE, Chen F, Christiani DC.

Cancer Epidemiol Biomarkers Prev. 2019 May;28(5):935-942. doi: 10.1158/1055-9965.EPI-18-0356. Epub 2019 Jan 30.

PMID:
30700444
6.

Identification of susceptibility pathways for the role of chromosome 15q25.1 in modifying lung cancer risk.

Ji X, Bossé Y, Landi MT, Gui J, Xiao X, Qian D, Joubert P, Lamontagne M, Li Y, Gorlov I, de Biasi M, Han Y, Gorlova O, Hung RJ, Wu X, McKay J, Zong X, Carreras-Torres R, Christiani DC, Caporaso N, Johansson M, Liu G, Bojesen SE, Le Marchand L, Albanes D, Bickeböller H, Aldrich MC, Bush WS, Tardon A, Rennert G, Chen C, Teare MD, Field JK, Kiemeney LA, Lazarus P, Haugen A, Lam S, Schabath MB, Andrew AS, Shen H, Hong YC, Yuan JM, Bertazzi PA, Pesatori AC, Ye Y, Diao N, Su L, Zhang R, Brhane Y, Leighl N, Johansen JS, Mellemgaard A, Saliba W, Haiman C, Wilkens L, Fernandez-Somoano A, Fernandez-Tardon G, van der Heijden EHFM, Kim JH, Dai J, Hu Z, Davies MPA, Marcus MW, Brunnström H, Manjer J, Melander O, Muller DC, Overvad K, Trichopoulou A, Tumino R, Doherty J, Goodman GE, Cox A, Taylor F, Woll P, Brüske I, Manz J, Muley T, Risch A, Rosenberger A, Grankvist K, Johansson M, Shepherd F, Tsao MS, Arnold SM, Haura EB, Bolca C, Holcatova I, Janout V, Kontic M, Lissowska J, Mukeria A, Ognjanovic S, Orlowski TM, Scelo G, Swiatkowska B, Zaridze D, Bakke P, Skaug V, Zienolddiny S, Duell EJ, Butler LM, Koh WP, Gao YT, Houlston R, McLaughlin J, Stevens V, Nickle DC, Obeidat M, Timens W, Zhu B, Song L, Artigas MS, Tobin MD, Wain LV, Gu F, Byun J, Kamal A, Zhu D, Tyndale RF, Wei WQ, Chanock S, Brennan P, Amos CI.

Nat Commun. 2018 Aug 13;9(1):3221. doi: 10.1038/s41467-018-05074-y.

7.

Genome-wide interaction study of smoking behavior and non-small cell lung cancer risk in Caucasian population.

Li Y, Xiao X, Han Y, Gorlova O, Qian D, Leighl N, Johansen JS, Barnett M, Chen C, Goodman G, Cox A, Taylor F, Woll P, Wichmann HE, Manz J, Muley T, Risch A, Rosenberger A, Arnold SM, Haura EB, Bolca C, Holcatova I, Janout V, Kontic M, Lissowska J, Mukeria A, Ognjanovic S, Orlowski TM, Scelo G, Swiatkowska B, Zaridze D, Bakke P, Skaug V, Zienolddiny S, Duell EJ, Butler LM, Houlston R, Soler Artigas M, Grankvist K, Johansson M, Shepherd FA, Marcus MW, Brunnström H, Manjer J, Melander O, Muller DC, Overvad K, Trichopoulou A, Tumino R, Liu G, Bojesen SE, Wu X, Marchand LL, Albanes D, Bickeböller H, Aldrich MC, Bush WS, Tardon A, Rennert G, Teare MD, Field JK, Kiemeney LA, Lazarus P, Haugen A, Lam S, Schabath MB, Andrew AS, Bertazzi PA, Pesatori AC, Christiani DC, Caporaso N, Johansson M, McKay JD, Brennan P, Hung RJ, Amos CI.

Carcinogenesis. 2018 Mar 8;39(3):336-346. doi: 10.1093/carcin/bgx113.

8.

Common TDP1 Polymorphisms in Relation to Survival among Small Cell Lung Cancer Patients: A Multicenter Study from the International Lung Cancer Consortium.

Lohavanichbutr P, Sakoda LC, Amos CI, Arnold SM, Christiani DC, Davies MPA, Field JK, Haura EB, Hung RJ, Kohno T, Landi MT, Liu G, Liu Y, Marcus MW, O'Kane GM, Schabath MB, Shiraishi K, Slone SA, Tardón A, Yang P, Yoshida K, Zhang R, Zong X, Goodman GE, Weiss NS, Chen C.

Clin Cancer Res. 2017 Dec 15;23(24):7550-7557. doi: 10.1158/1078-0432.CCR-17-1401. Epub 2017 Oct 3.

9.

Age at menopause and hormone replacement therapy as risk factors for head and neck and oesophageal cancer (Review).

McCarthy CE, Field JK, Marcus MW.

Oncol Rep. 2017 Oct;38(4):1915-1922. doi: 10.3892/or.2017.5867. Epub 2017 Aug 1. Review.

PMID:
28765919
10.

Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes.

McKay JD, Hung RJ, Han Y, Zong X, Carreras-Torres R, Christiani DC, Caporaso NE, Johansson M, Xiao X, Li Y, Byun J, Dunning A, Pooley KA, Qian DC, Ji X, Liu G, Timofeeva MN, Bojesen SE, Wu X, Le Marchand L, Albanes D, Bickeböller H, Aldrich MC, Bush WS, Tardon A, Rennert G, Teare MD, Field JK, Kiemeney LA, Lazarus P, Haugen A, Lam S, Schabath MB, Andrew AS, Shen H, Hong YC, Yuan JM, Bertazzi PA, Pesatori AC, Ye Y, Diao N, Su L, Zhang R, Brhane Y, Leighl N, Johansen JS, Mellemgaard A, Saliba W, Haiman CA, Wilkens LR, Fernandez-Somoano A, Fernandez-Tardon G, van der Heijden HFM, Kim JH, Dai J, Hu Z, Davies MPA, Marcus MW, Brunnström H, Manjer J, Melander O, Muller DC, Overvad K, Trichopoulou A, Tumino R, Doherty JA, Barnett MP, Chen C, Goodman GE, Cox A, Taylor F, Woll P, Brüske I, Wichmann HE, Manz J, Muley TR, Risch A, Rosenberger A, Grankvist K, Johansson M, Shepherd FA, Tsao MS, Arnold SM, Haura EB, Bolca C, Holcatova I, Janout V, Kontic M, Lissowska J, Mukeria A, Ognjanovic S, Orlowski TM, Scelo G, Swiatkowska B, Zaridze D, Bakke P, Skaug V, Zienolddiny S, Duell EJ, Butler LM, Koh WP, Gao YT, Houlston RS, McLaughlin J, Stevens VL, Joubert P, Lamontagne M, Nickle DC, Obeidat M, Timens W, Zhu B, Song L, Kachuri L, Artigas MS, Tobin MD, Wain LV; SpiroMeta Consortium, Rafnar T, Thorgeirsson TE, Reginsson GW, Stefansson K, Hancock DB, Bierut LJ, Spitz MR, Gaddis NC, Lutz SM, Gu F, Johnson EO, Kamal A, Pikielny C, Zhu D, Lindströem S, Jiang X, Tyndale RF, Chenevix-Trench G, Beesley J, Bossé Y, Chanock S, Brennan P, Landi MT, Amos CI.

Nat Genet. 2017 Jul;49(7):1126-1132. doi: 10.1038/ng.3892. Epub 2017 Jun 12.

11.

Obesity, metabolic factors and risk of different histological types of lung cancer: A Mendelian randomization study.

Carreras-Torres R, Johansson M, Haycock PC, Wade KH, Relton CL, Martin RM, Davey Smith G, Albanes D, Aldrich MC, Andrew A, Arnold SM, Bickeböller H, Bojesen SE, Brunnström H, Manjer J, Brüske I, Caporaso NE, Chen C, Christiani DC, Christian WJ, Doherty JA, Duell EJ, Field JK, Davies MPA, Marcus MW, Goodman GE, Grankvist K, Haugen A, Hong YC, Kiemeney LA, van der Heijden EHFM, Kraft P, Johansson MB, Lam S, Landi MT, Lazarus P, Le Marchand L, Liu G, Melander O, Park SL, Rennert G, Risch A, Haura EB, Scelo G, Zaridze D, Mukeriya A, Savić M, Lissowska J, Swiatkowska B, Janout V, Holcatova I, Mates D, Schabath MB, Shen H, Tardon A, Teare MD, Woll P, Tsao MS, Wu X, Yuan JM, Hung RJ, Amos CI, McKay J, Brennan P.

PLoS One. 2017 Jun 8;12(6):e0177875. doi: 10.1371/journal.pone.0177875. eCollection 2017.

12.

AURKA mRNA expression is an independent predictor of poor prognosis in patients with non-small cell lung cancer.

Al-Khafaji ASK, Marcus MW, Davies MPA, Risk JM, Shaw RJ, Field JK, Liloglou T.

Oncol Lett. 2017 Jun;13(6):4463-4468. doi: 10.3892/ol.2017.6012. Epub 2017 Apr 7.

13.

Association between smoking and health outcomes in an economically deprived population: the Liverpool Lung Project.

Sherratt FC, Field JK, Marcus MW.

J Epidemiol Community Health. 2017 Aug;71(8):806-810. doi: 10.1136/jech-2016-208730. Epub 2017 Apr 17.

PMID:
28416569
14.

Risk assessment in relation to the detection of small pulmonary nodules.

Field JK, Marcus MW, Oudkerk M.

Transl Lung Cancer Res. 2017 Feb;6(1):35-41. doi: 10.21037/tlcr.2017.02.05. Review.

15.

Is Bootstrapping Sufficient for Validating a Risk Model for Selection of Participants for a Lung Cancer Screening Program?

Marcus MW, Field JK.

J Clin Oncol. 2017 Mar 10;35(8):818-819. doi: 10.1200/JCO.2016.71.3214. Epub 2017 Jan 23. No abstract available.

PMID:
28113026
16.

Aurora B expression modulates paclitaxel response in non-small cell lung cancer.

Al-Khafaji AS, Davies MP, Risk JM, Marcus MW, Koffa M, Gosney JR, Shaw RJ, Field JK, Liloglou T.

Br J Cancer. 2017 Feb 28;116(5):592-599. doi: 10.1038/bjc.2016.453. Epub 2017 Jan 17.

17.

Utilizing Lung Cancer Risk Prediction Models to Promote Smoking Cessation: Two Randomized Controlled Trials.

Sherratt FC, Marcus MW, Robinson J, Field JK.

Am J Health Promot. 2018 Jun;32(5):1196-1205. doi: 10.1177/0890117116673820. Epub 2016 Oct 25.

PMID:
27780895
18.

Incorporating epistasis interaction of genetic susceptibility single nucleotide polymorphisms in a lung cancer risk prediction model.

Marcus MW, Raji OY, Duffy SW, Young RP, Hopkins RJ, Field JK.

Int J Oncol. 2016 Jul;49(1):361-70. doi: 10.3892/ijo.2016.3499. Epub 2016 Apr 25.

19.

Associated Links Among Smoking, Chronic Obstructive Pulmonary Disease, and Small Cell Lung Cancer: A Pooled Analysis in the International Lung Cancer Consortium.

Huang R, Wei Y, Hung RJ, Liu G, Su L, Zhang R, Zong X, Zhang ZF, Morgenstern H, Brüske I, Heinrich J, Hong YC, Kim JH, Cote M, Wenzlaff A, Schwartz AG, Stucker I, Mclaughlin J, Marcus MW, Davies MP, Liloglou T, Field JK, Matsuo K, Barnett M, Thornquist M, Goodman G, Wang Y, Chen S, Yang P, Duell EJ, Andrew AS, Lazarus P, Muscat J, Woll P, Horsman J, Teare MD, Flugelman A, Rennert G, Zhang Y, Brenner H, Stegmaier C, van der Heijden EH, Aben K, Kiemeney L, Barros-Dios J, Pérez-Ríos M, Ruano-Ravina A, Caporaso NE, Bertazzi PA, Landi MT, Dai J, Hongbing Shen H, Fernandez-Tardon G, Rodriguez-Suarez M, Tardon A, Christiani DC.

EBioMedicine. 2015 Nov;2(11):1677-85.

20.

Perceptions towards electronic cigarettes for smoking cessation among Stop Smoking Service users.

Sherratt FC, Newson L, Marcus MW, Field JK, Robinson J.

Br J Health Psychol. 2016 May;21(2):421-33. doi: 10.1111/bjhp.12177. Epub 2015 Dec 16.

PMID:
26671555
21.

Fine mapping of chromosome 5p15.33 based on a targeted deep sequencing and high density genotyping identifies novel lung cancer susceptibility loci.

Kachuri L, Amos CI, McKay JD, Johansson M, Vineis P, Bueno-de-Mesquita HB, Boutron-Ruault MC, Johansson M, Quirós JR, Sieri S, Travis RC, Weiderpass E, Le Marchand L, Henderson BE, Wilkens L, Goodman GE, Chen C, Doherty JA, Christiani DC, Wei Y, Su L, Tworoger S, Zhang X, Kraft P, Zaridze D, Field JK, Marcus MW, Davies MPA, Hyde R, Caporaso NE, Landi MT, Severi G, Giles GG, Liu G, McLaughlin JR, Li Y, Xiao X, Fehringer G, Zong X, Denroche RE, Zuzarte PC, McPherson JD, Brennan P, Hung RJ.

Carcinogenesis. 2016 Jan;37(1):96-105. doi: 10.1093/carcin/bgv165. Epub 2015 Nov 20.

22.

Lung cancer among coal miners, ore miners and quarrymen: smoking-adjusted risk estimates from the synergy pooled analysis of case-control studies.

Taeger D, Pesch B, Kendzia B, Behrens T, Jöckel KH, Dahmann D, Siemiatycki J, Kromhout H, Vermeulen R, Peters S, Olsson A, Brüske I, Wichmann HE, Stücker I, Guida F, Tardón A, Merletti F, Mirabelli D, Richiardi L, Pohlabeln H, Ahrens W, Landi MT, Caporaso N, Pesatori AC, Mukeriya A, Szeszenia-Dabrowska N, Lissowska J, Gustavsson P, Field J, Marcus MW, Fabianova E, 't Mannetje A, Pearce N, Rudnai P, Bencko V, Janout V, Dumitru RS, Foretova L, Forastiere F, McLaughlin J, Paul Demers PD, Bueno-de-Mesquita B, Schüz J, Straif K, Brüning T.

Scand J Work Environ Health. 2015 Sep 1;41(5):467-77. doi: 10.5271/sjweh.3513. Epub 2015 Jul 8.

23.

Lung cancer trend in England for the period of 2002 to 2011 and projections of future burden until 2020.

Olajide OO, Field JK, Davies MM, Marcus MW.

Int J Oncol. 2015 Aug;47(2):739-46. doi: 10.3892/ijo.2015.3049. Epub 2015 Jun 15.

PMID:
26081553
24.

Lung cancer screening: identifying the high risk cohort.

Marcus MW, Raji OY, Field JK.

J Thorac Dis. 2015 Apr;7(Suppl 2):S156-62. doi: 10.3978/j.issn.2072-1439.2015.04.19. Review.

25.

Trends and regional variation in the incidence of head and neck cancers in England: 2002 to 2011.

McCarthy CE, Field JK, Rajlawat BP, Field AE, Marcus MW.

Int J Oncol. 2015 Jul;47(1):204-10. doi: 10.3892/ijo.2015.2990. Epub 2015 May 7.

PMID:
25955390
26.

LLPi: Liverpool Lung Project Risk Prediction Model for Lung Cancer Incidence.

Marcus MW, Chen Y, Raji OY, Duffy SW, Field JK.

Cancer Prev Res (Phila). 2015 Jun;8(6):570-5. doi: 10.1158/1940-6207.CAPR-14-0438. Epub 2015 Apr 14.

27.

Impact of comorbidity on lung cancer mortality - a report from the Liverpool Lung Project.

Marcus MW, Chen Y, Duffy SW, Field JK.

Oncol Lett. 2015 Apr;9(4):1902-1906. Epub 2015 Jan 28.

28.

Unique volatolomic signatures of TP53 and KRAS in lung cells.

Davies MP, Barash O, Jeries R, Peled N, Ilouze M, Hyde R, Marcus MW, Field JK, Haick H.

Br J Cancer. 2014 Sep 9;111(6):1213-21. doi: 10.1038/bjc.2014.411. Epub 2014 Jul 22.

29.

Factors associated with dropout in a lung cancer high‑risk cohort--the Liverpool lung project.

Marcus MW, Raji OY, Chen Y, Duffy SW, Field JK.

Int J Oncol. 2014 Jun;44(6):2146-52. doi: 10.3892/ijo.2014.2371. Epub 2014 Apr 7.

PMID:
24714788
30.

Lung cancer risk among hairdressers: a pooled analysis of case-control studies conducted between 1985 and 2010.

Olsson AC, Xu Y, Schüz J, Vlaanderen J, Kromhout H, Vermeulen R, Peters S, Stücker I, Guida F, Brüske I, Wichmann HE, Consonni D, Landi MT, Caporaso N, Tse LA, Yu IT, Siemiatycki J, Richardson L, Mirabelli D, Richiardi L, Simonato L, Gustavsson P, Plato N, Jöckel KH, Ahrens W, Pohlabeln H, Tardón A, Zaridze D, Marcus MW, 't Mannetje A, Pearce N, McLaughlin J, Demers P, Szeszenia-Dabrowska N, Lissowska J, Rudnai P, Fabianova E, Dumitru RS, Bencko V, Foretova L, Janout V, Boffetta P, Fortes C, Bueno-de-Mesquita B, Kendzia B, Behrens T, Pesch B, Brüning T, Straif K.

Am J Epidemiol. 2013 Nov 1;178(9):1355-65. doi: 10.1093/aje/kwt119. Epub 2013 Sep 25.

31.

The contribution of risk prediction models to early detection of lung cancer.

Field JK, Chen Y, Marcus MW, Mcronald FE, Raji OY, Duffy SW.

J Surg Oncol. 2013 Oct;108(5):304-11. doi: 10.1002/jso.23384. Epub 2013 Aug 29. Review.

PMID:
23996507
32.

Corticosteroids and open-angle glaucoma in the elderly: a population-based cohort study.

Marcus MW, Müskens RP, Ramdas WD, Wolfs RC, De Jong PT, Vingerling JR, Hofman A, Stricker BH, Jansonius NM.

Drugs Aging. 2012 Dec;29(12):963-70. doi: 10.1007/s40266-012-0029-9.

PMID:
23150239
33.

Antithrombotic medication and incident open-angle glaucoma.

Marcus MW, Müskens RP, Ramdas WD, Wolfs RC, de Jong PT, Vingerling JR, Hofman A, Stricker BH, Jansonius NM.

Invest Ophthalmol Vis Sci. 2012 Jun 20;53(7):3801-5. doi: 10.1167/iovs.12-9604.

PMID:
22589449
34.

Cholesterol-lowering drugs and incident open-angle glaucoma: a population-based cohort study.

Marcus MW, Müskens RP, Ramdas WD, Wolfs RC, De Jong PT, Vingerling JR, Hofman A, Stricker BH, Jansonius NM.

PLoS One. 2012;7(1):e29724. doi: 10.1371/journal.pone.0029724. Epub 2012 Jan 4.

35.

Risk factors for visual field progression in the groningen longitudinal glaucoma study: a comparison of different statistical approaches.

Wesselink C, Marcus MW, Jansonius NM.

J Glaucoma. 2012 Dec;21(9):579-85. doi: 10.1097/IJG.0b013e31822543e0. Erratum in: J Glaucoma. 2014 Jan;23(1):60.

PMID:
21701396
36.

Myopia as a risk factor for open-angle glaucoma: a systematic review and meta-analysis.

Marcus MW, de Vries MM, Junoy Montolio FG, Jansonius NM.

Ophthalmology. 2011 Oct;118(10):1989-1994.e2. doi: 10.1016/j.ophtha.2011.03.012. Review.

PMID:
21684603

Supplemental Content

Loading ...
Support Center